Exome and Genome Sequencing and Parallels in Radiology: Searching for Patient-Centered Management of Incidental and Secondary Findings

被引:5
|
作者
Kang, Stella K. [1 ,2 ]
Spector-Bagdady, Kayte [3 ]
Caplan, Arthur L. [4 ]
Braithwaite, R. Scott [2 ,5 ]
机构
[1] NYU, Sch Med, Dept Radiol, New York, NY USA
[2] NYU, Sch Med, Dept Populat Hlth, New York, NY USA
[3] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI USA
[4] NYU, Dept Populat Hlth, Div Med Eth, Sch Med, New York, NY USA
[5] NYU, Sch Med, Dept Med, New York, NY USA
关键词
Incidental finding; genome sequencing; patient-centered care; WHITE PAPER; COMMITTEE II; PELVIC CT; AUTONOMY; RETURN; MRI;
D O I
10.1016/j.jacr.2016.06.050
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Incidental and secondary findings have become an important by-product of diagnostic testing, and their ramifications affect clinical care, research, and policy. Given parallels in the reporting and management of such findings on diagnostic imaging, radiologists may draw from ongoing discussions in medical genetics to rethink more patient-centered approaches to analogous clinical, ethical, and medicolegal dilemmas. Low-risk incidental findings in particular may be drivers of unnecessary testing, invasive procedures, and overtreatment, with associated financial, psychological, and clinical consequences. As radiologists act in patients' best interests by strengthening standardized guidelines on how each finding merits further diagnostic testing or treatment, perhaps the greatest challenge for producing such guidelines is for low-risk incidental findings, for which adverse consequences are unlikely but associated with substantial uncertainty because of the lack of strong evidence on which to base the recommendations. More uniform recommendations for managing low-risk radiologic incidental findings should therefore aim to provide reasonable options that apply across a spectrum of patient preferences. These will require evaluation through research and will ultimately influence the quality of care. Specific areas for exploration may include (1) better gauging of patient attitudes and preferences regarding low-risk incidental findings, (2) using patient preferences to inform more uniform recommendations for low-risk findings that apply across a spectrum of preferences and help guide shared decision making, and (3) when patients endorse a strong preference not to discover low-risk incidental findings, how it might be possible for professional standards to curtail their generation in specific circumstances.
引用
收藏
页码:1467 / 1472
页数:6
相关论文
共 43 条
  • [1] Patient-centered, value-based management of incidental findings in radiology
    Weckbach, Sabine
    Wielpuetz, Mark O.
    von Stackelberg, Oyunbileg
    RADIOLOGIE, 2023, 63 (09): : 657 - 664
  • [2] Incidental and secondary findings in trio exome sequencing
    Cohen, Camille
    Bellanger, Emeline
    Mortreux, Jeremie
    Raymond, Laure
    Vialard, Francois
    Dard, Rodolphe
    GENES & DISEASES, 2024, 11 (04)
  • [3] Who's on first in exome and whole genome sequencing? Is it the patient or the incidental findings?
    Rosenblatt, David S.
    MOLECULAR GENETICS AND METABOLISM, 2013, 110 (1-2) : 1 - 2
  • [4] ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
    Green, Robert C.
    Berg, Jonathan S.
    Grody, Wayne W.
    Kalia, Sarah S.
    Korf, Bruce R.
    Martin, Christa L.
    McGuire, Amy L.
    Nussbaum, Robert L.
    O'Daniel, Julianne M.
    Ormond, Kelly E.
    Rehm, Heidi L.
    Watson, Michael S.
    Williams, Marc S.
    Biesecker, Leslie G.
    GENETICS IN MEDICINE, 2013, 15 (07) : 565 - 574
  • [5] Frequency and management of medically actionable incidental findings from genome and exome sequencing data: a systematic review
    Elfatih, Amal
    Mohammed, Idris
    Abdelrahman, Doua
    Mifsud, Borbala
    PHYSIOLOGICAL GENOMICS, 2021, 53 (09) : 373 - 384
  • [6] On the Justifiability of ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing
    May, Thomas
    JOURNAL OF LAW MEDICINE & ETHICS, 2015, 43 (01): : 134 - 142
  • [7] Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing
    Allyse, Megan
    Michie, Marsha
    TRENDS IN BIOTECHNOLOGY, 2013, 31 (08) : 439 - 441
  • [8] Management of secondary findings from whole exome/genome sequencing: a first step into genomic medicine
    Delanne, J.
    Putois, O.
    Chassagne, A.
    Cretin, E.
    Pelissier, A.
    Peyron, C.
    Gauthier, E.
    Thevenon, J.
    Nambot, S.
    Kuentz, P.
    Bruel, A.
    Skrzypski, J.
    Ghiringhelli, F.
    Boidot, R.
    Lehalle, D.
    Jean-Marcais, N.
    Callier, P.
    Mosca-Boidron, A.
    Vabres, P.
    Demougeot, L.
    Poe, C.
    Jouan, T.
    Chevarin, M.
    Lefebvre, M.
    Bardou, M.
    Tisserant, E.
    Luu, M.
    Philippe, C.
    Them, F. Tran Mau
    Binquet, C.
    Duffourd, Y.
    Thauvin-Robinet, C.
    Faivre, L.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 694 - 695
  • [9] Secondary findings from whole exome or genome sequencing: psychological and ethical Issues. Patient point of view
    Houdayer, F.
    Putois, O.
    Staraci, S.
    Babonneau, M. L.
    Michon, C. C.
    Chaumet, H.
    Joly, L.
    Juif, C.
    Chassagne, A.
    Gautier, E.
    Thauvin-Robinet, C.
    Sanlaville, D.
    Edery, P.
    Lapointe, A. S.
    Garguilo, M.
    Faivre, L.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 686 - 687
  • [10] Secondary And Incidental Findings in A Cohort of Patients with Immune-Mediated Disease Undergoing Exome Sequencing
    Setzer, Michael
    Similuk, Morgan
    Walkiewicz, Magdalena
    Holland, Steven
    JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (SUPPL 1) : S38 - S39